Bio-Rad Laboratories (BIO) Gross Profit Margin: History & Chart

Bio-Rad Laboratories, Inc.(BIO)

Medical - Devices · Hercules, CA

$369.32+0.57 (+0.15%)

Delayed quote: Sep 11, 2026, 4:00 PM EDT

About Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules, California, operates as a global provider of life science research and clinical diagnostic products. Its operations span across the United States, Canada, Europe, Asia, and Latin America. The company is organized into two primary divisions: Life Science and Clinical Diagnostics. The Life Science division is responsible for developing, manufacturing, and commercializing a diverse array of reagents, equipment, and laboratory instruments. These products are crucial for various research methodologies, biopharmaceutical manufacturing processes, and food quality testing. This segment focuses on specialized areas within the life sciences, including proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. Its clientele encompasses academic institutions (such as universities and medical schools), industrial research organizations, government agencies, pharmaceutical companies, biotechnology firms, food producers, and food testing laboratories. In contrast, the Clinical Diagnostics division designs, produces, sells, and supports a comprehensive suite of test systems, informatics solutions, diagnostic kits, and specialized quality control products for clinical laboratories. This segment provides reagents, instruments, and software specifically tailored for particular niches within the in vitro diagnostics market. Its customer base includes reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. Beyond these core segments, Bio-Rad also offers systems and products designed to separate complex chemical and biological materials, as well as to identify, analyze, and purify their individual components. The company distributes its extensive product portfolio through a combination of its direct sales force and a network of third-party distributors, agents, brokers, and resellers.

Hercules, CA

7,450 employees

www.bio-rad.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Norman D. Schwartz

View full financials

BIO Gross Margin Metrics

GROSS MARGIN

51.90%

GROSS MARGIN AVG TTM

52.15%

GROSS MARGIN AVG 3Y

52.97%

GROSS MARGIN AVG 5Y

54.04%

GROSS MARGIN AVG 10Y

54.32%

GROSS MARGIN AVG 15Y

54.79%

GROSS MARGIN AVG 20Y

55.04%

CURRENT VS TTM AVG

-0.48%

CURRENT VS 3Y AVG

-2.03%

CURRENT VS 5Y AVG

-3.96%

CURRENT VS 10Y AVG

-4.46%

CURRENT VS 15Y AVG

-5.27%

CURRENT VS 20Y AVG

-5.71%

SECTOR MEDIAN · HEALTHCARE

58.99%

median of 90 covered companies

CURRENT VS SECTOR MEDIAN

-12.03%

vs the sector median at left

NAME	MARKET CAP	GROSS MARGIN	TTM	3Y	5Y
Bio-Rad Laboratories, Inc. (BIO)	$9.94B	51.90%	52.15%	52.97%	54.04%
Globus Medical, Inc. (GMED)vs ›	$10.01B	68.55%	63.16%	66.39%	68.84%
Henry Schein, Inc. (HSIC)vs ›	$10.07B	30.31%	29.43%	29.32%	29.12%
The Ensign Group, Inc. (ENSG)vs ›	$10.14B	14.14%	15.74%	16.11%	16.54%
Tempus AI, Inc. (TEM)vs ›	$10.34B	63.98%	58.85%	53.03%	43.30%
The Cooper Companies, Inc. (COO)vs ›	$10.51B	64.75%	63.66%	64.40%	64.61%
Universal Health Services, Inc. (UHS)vs ›	$10.58B	90.69%	90.21%	89.67%	89.38%
Molina Healthcare, Inc. (MOH)vs ›	$10.66B	13.07%	12.36%	12.43%	12.55%
Insulet Corp. (PODD)vs ›	$9.14B	71.08%	70.71%	67.87%	67.39%
Align Technology, Inc. (ALGN)vs ›	$10.80B	66.48%	69.16%	69.73%	70.75%

NAME

MARKET CAP

GROSS MARGIN

TTM

Bio-Rad Laboratories, Inc. (BIO)

$9.94B

51.90%

52.15%

52.97%

54.04%

Globus Medical, Inc. (GMED)vs ›

$10.01B

68.55%

63.16%

66.39%

68.84%

Henry Schein, Inc. (HSIC)vs ›

$10.07B

30.31%

29.43%

29.32%

29.12%

The Ensign Group, Inc. (ENSG)vs ›

$10.14B

14.14%

15.74%

16.11%

16.54%

Tempus AI, Inc. (TEM)vs ›

$10.34B

63.98%

58.85%

53.03%

43.30%

The Cooper Companies, Inc. (COO)vs ›

$10.51B

64.75%

63.66%

64.40%

64.61%

Universal Health Services, Inc. (UHS)vs ›

$10.58B

90.69%

90.21%

89.67%

89.38%

Molina Healthcare, Inc. (MOH)vs ›

$10.66B

13.07%

12.36%

12.43%

12.55%

Insulet Corp. (PODD)vs ›

$9.14B

71.08%

70.71%

67.87%

67.39%

Align Technology, Inc. (ALGN)vs ›

$10.80B

66.48%

69.16%

69.73%

70.75%

Gross Margin FAQ

What is the gross margin for Bio-Rad Laboratories, Inc. (BIO)?

The gross margin for BIO stock is 51.90%.

Is Bio-Rad Laboratories, Inc.'s gross margin high or low?

The gross margin of 51.90% is in line with its 5-year average of 54.04%, near the low end of its 5-year range (49.80%–58.56%).

What is the TTM average gross margin for Bio-Rad Laboratories, Inc. (BIO)?

The TTM average gross margin for BIO stock is 52.15%.

What is the 3Y average gross margin for Bio-Rad Laboratories, Inc. (BIO)?

The 3Y average gross margin for BIO stock is 52.97%.

What is the 5Y average gross margin for Bio-Rad Laboratories, Inc. (BIO)?

The 5Y average gross margin for BIO stock is 54.04%.

What is the 10Y average gross margin for Bio-Rad Laboratories, Inc. (BIO)?

The 10Y average gross margin for BIO stock is 54.32%.

What is the 15Y average gross margin for Bio-Rad Laboratories, Inc. (BIO)?

The 15Y average gross margin for BIO stock is 54.79%.

What is the 20Y average gross margin for Bio-Rad Laboratories, Inc. (BIO)?

The 20Y average gross margin for BIO stock is 55.04%.

DATE	GROSS MARGIN
2026-06-30	53.12%
2026-03-31	52.25%
2025-12-31	49.80%
2025-09-30	52.59%
2025-06-30	52.99%
2025-03-31	52.27%
2024-12-31	51.22%
2024-09-30	54.78%
2024-06-30	55.62%
2024-03-31	53.45%
2023-12-31	53.72%
2023-09-30	53.10%
2023-06-30	53.22%
2023-03-31	53.55%
2022-12-31	54.38%
2022-09-30	54.90%
2022-06-30	57.30%
2022-03-31	57.51%
2021-12-31	54.72%
2021-09-30	58.56%
2021-06-30	56.09%
2021-03-31	55.12%
2020-12-31	58.26%
2020-09-30	56.75%
2020-06-30	54.57%
2020-03-31	55.52%
2019-12-31	52.92%
2019-09-30	54.76%
2019-06-30	53.75%
2019-03-31	56.28%
2018-12-31	54.05%
2018-09-30	52.60%
2018-06-30	52.38%
2018-03-31	54.79%
2017-12-31	54.73%
2017-09-30	56.92%
2017-06-30	54.15%
2017-03-31	53.99%
2016-12-31	55.01%
2016-09-30	54.93%
2016-06-30	54.23%
2016-03-31	56.03%
2015-12-31	54.07%
2015-09-30	56.06%
2015-06-30	55.25%
2015-03-31	57.13%
2014-12-31	53.06%
2014-09-30	54.38%
2014-06-30	55.37%
2014-03-31	54.05%
2013-12-31	53.56%
2013-09-30	56.27%
2013-06-30	57.13%
2013-03-31	54.32%
2012-12-31	55.95%
2012-09-30	54.84%
2012-06-30	56.40%
2012-03-31	57.29%
2011-12-31	56.51%
2011-09-30	57.34%
2011-06-30	56.19%
2011-03-31	57.23%
2010-12-31	56.16%
2010-09-30	56.49%
2010-06-30	57.37%
2010-03-31	56.61%
2009-12-31	54.23%
2009-09-30	56.50%
2009-06-30	56.64%
2009-03-31	57.09%
2008-12-31	55.07%
2008-09-30	54.44%
2008-06-30	54.92%
2008-03-31	53.74%
2007-12-31	50.82%
2007-09-30	55.44%
2007-06-30	56.03%
2007-03-31	55.62%
2006-12-31	54.09%
2006-09-30	54.73%
2006-06-30	58.12%
2006-03-31	56.93%
2005-12-31	52.92%
2005-09-30	55.37%
2005-06-30	55.15%
2005-03-31	55.62%
2004-12-31	54.68%
2004-09-30	55.17%
2004-06-30	57.44%
2004-03-31	56.55%
2003-12-31	55.92%
2003-09-30	55.48%
2003-06-30	56.02%
2003-03-31	58.02%
2002-12-31	56.31%
2002-09-30	57.38%

DATE

GROSS MARGIN

2026-06-30

53.12%

2026-03-31

52.25%

2025-12-31

49.80%

2025-09-30

52.59%

2025-06-30

52.99%

2025-03-31

52.27%

2024-12-31

51.22%

2024-09-30

54.78%

2024-06-30

55.62%

2024-03-31

53.45%

2023-12-31

53.72%

2023-09-30

53.10%

2023-06-30

53.22%

2023-03-31

53.55%

2022-12-31

54.38%

2022-09-30

54.90%

2022-06-30

57.30%

2022-03-31

57.51%

2021-12-31

54.72%

2021-09-30

58.56%

2021-06-30

56.09%

2021-03-31

55.12%

2020-12-31

58.26%

2020-09-30

56.75%

2020-06-30

54.57%

2020-03-31

55.52%

2019-12-31

52.92%

2019-09-30

54.76%

2019-06-30

53.75%

2019-03-31

56.28%

2018-12-31

54.05%

2018-09-30

52.60%

2018-06-30

52.38%

2018-03-31

54.79%

2017-12-31

54.73%

2017-09-30

56.92%

2017-06-30

54.15%

2017-03-31

53.99%

2016-12-31

55.01%

2016-09-30

54.93%

2016-06-30

54.23%

2016-03-31

56.03%

2015-12-31

54.07%

2015-09-30

56.06%

2015-06-30

55.25%

2015-03-31

57.13%

2014-12-31

53.06%

2014-09-30

54.38%

2014-06-30

55.37%

2014-03-31

54.05%

2013-12-31

53.56%

2013-09-30

56.27%

2013-06-30

57.13%

2013-03-31

54.32%

2012-12-31

55.95%

2012-09-30

54.84%

2012-06-30

56.40%

2012-03-31

57.29%

2011-12-31

56.51%

2011-09-30

57.34%

2011-06-30

56.19%

2011-03-31

57.23%

2010-12-31

56.16%

2010-09-30

56.49%

2010-06-30

57.37%

2010-03-31

56.61%

2009-12-31

54.23%

2009-09-30

56.50%

2009-06-30

56.64%

2009-03-31

57.09%

2008-12-31

55.07%

2008-09-30

54.44%

2008-06-30

54.92%

2008-03-31

53.74%

2007-12-31

50.82%

2007-09-30

55.44%

2007-06-30

56.03%

2007-03-31

55.62%

2006-12-31

54.09%

2006-09-30

54.73%

2006-06-30

58.12%

2006-03-31

56.93%

2005-12-31

52.92%

2005-09-30

55.37%

2005-06-30

55.15%

2005-03-31

55.62%

2004-12-31

54.68%

2004-09-30

55.17%

2004-06-30

57.44%

2004-03-31

56.55%

2003-12-31

55.92%

2003-09-30

55.48%

2003-06-30

56.02%

2003-03-31

58.02%

2002-12-31

56.31%

2002-09-30

57.38%

Gross Margin: 51.90%

BIO Gross Margin

BIO Average Gross Margin Chart

BIO Current vs Average Gross Margin Chart

BIO Gross Margin Metrics

BIO Competitors' Gross Margin

Gross Margin Analysis

Gross Margin Formula & Definition

Gross Margin FAQ

BIO Gross Margin History

Related Metrics